BackCoeptis Therapeutics Holdings- Warrants (31/10/2025) Overview

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Current Liabilities

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s total current liabilities is $1.8M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.82M
67.85% YoYΔ $-3.83M vs prior year quarter

Peer average

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Current Liabilities History

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) vs. peers: Total Current Liabilities Comparison

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Coeptis Therapeutics Holdings- Warrants (31/10/2025) (COEPW) FAQ

The latest total current liabilities for COEPW is $1.8M as of March 2026. That compares with $5.7M in the prior-year period — down 67.8% year over year. Investors often review this figure alongside Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, COEPW's total current liabilities moved from $5.7M to $1.8M — a 67.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s operating scale or balance-sheet position.

A total current liabilities figure of $1.8M for COEPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting COEPW's total current liabilities ($1.8M), review year-over-year change from $5.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.